What is Lightship?
Lightship operates as a premier clinical trial services provider, fundamentally redefining how research is conducted through its decentralized and hybrid trial frameworks. By moving away from traditional, centralized brick-and-mortar facilities, the company utilizes a community-based approach that integrates advanced digital connectivity with physical infrastructure. This includes the deployment of Mobile Research Units and a specialized network of mobile nurses who bring clinical visits directly to the patient's home. This model not only enhances patient recruitment and retention but also ensures that clinical data collection is more inclusive, diverse, and representative of the broader population, thereby accelerating the development of new therapies.
How much funding has Lightship raised?
Lightship has raised a total of $64.9M across 3 funding rounds:
Series A
$4.9M
Series B
$20M
Unspecified
$40M
Series A (2019): $4.9M, investors not publicly disclosed
Series B (2020): $20M led by Marc Benioff, Khosla Ventures, McKesson, Brook Byers, and Define Ventures Management
Unspecified (2021): $40M supported by McKesson, TIME Ventures, Khosla Ventures, and Define Ventures Management
Key Investors in Lightship
Khosla Ventures
Khosla Ventures provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies, with a strong focus on health, AI, and enterprise solutions.
McKesson
McKesson Corporation is a global leader in pharmaceutical distribution and healthcare technology, providing critical supply chain and clinical support solutions to the medical industry.
Define Ventures Management
Define Ventures is an early-stage venture capital firm that specializes in investing in high-growth digital health companies.
What's next for Lightship?
With the support of its latest strategic backing, Lightship is poised to expand its footprint in the global clinical research market. The company's roadmap likely involves scaling its fleet of Mobile Research Units and enhancing its digital platform to support more complex, multi-site trials. As the industry shifts toward more flexible, patient-first research methodologies, Lightship is strategically positioned to become the standard-bearer for decentralized clinical operations. Future growth will likely focus on deepening partnerships with pharmaceutical manufacturers and healthcare providers to streamline the drug development lifecycle, ultimately reducing the time and cost associated with bringing innovative treatments to market.
See full Lightship company page
